Literature DB >> 10192746

Interleukin-1alpha concentration in tumors as a risk factor for liver metastasis in gastric cancer.

Y Furuya1, T Ichikura, H Mochizuki.   

Abstract

To investigate the relationship between the concentration of interleukin-1alpha (IL-1alpha) and liver metastasis in gastric cancer, the concentration of IL-1alpha was measured in homogenized tumor samples from 61 patients with gastric cancer. A significantly higher concentration of IL-1alpha was observed in tumors from patients with liver metastasis than in those from patients without liver metastasis; in differentiated type tumors than in undifferentiated type tumors; in tumors associated with moderate to severe venous invasion than in those associated with mild or no invasion; and in tumors with expansive or intermediate growth pattern (INFalpha, INFbeta) than in those with an infiltrative pattern (INFgamma) by Student's t-test. Stepwise logistic regression revealed IL-1alpha, depth of invasion, venous invasion, and tumor size to be associated independently with liver metastasis. These findings led us to conclude that the IL-1alpha concentration was on eof the most useful determinants of liver metastasis among the various clinicopathologic characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192746     DOI: 10.1007/bf02483025

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  Augmentation of tumor metastasis by platelet-activating factor.

Authors:  S Y Im; H M Ko; J W Kim; H K Lee; T Y Ha; H B Lee; S J Oh; S Bai; K C Chung; Y B Lee; H S Kang; S B Chun
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

2.  Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.

Authors:  E Lengyel; J Klostergaard; D Boyd
Journal:  Biochim Biophys Acta       Date:  1995-07-20

3.  Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells.

Authors:  R Ito; Y Kitadai; E Kyo; H Yokozaki; W Yasui; U Yamashita; H Nikai; E Tahara
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

4.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.

Authors:  A R Mackay; M Ballin; M D Pelina; A R Farina; A M Nason; J L Hartzler; U P Thorgeirsson
Journal:  Invasion Metastasis       Date:  1992

Review 5.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

6.  Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma.

Authors:  S Kabir; G A Daar
Journal:  Cancer Lett       Date:  1995-08-16       Impact factor: 8.679

7.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  E-selectin: sialyl Lewis, a dependent adhesion of colon cancer cells, is inhibited differently by antibodies against E-selectin ligands.

Authors:  U Srinivas; P Påhlsson; A Lundblad
Journal:  Scand J Immunol       Date:  1996-09       Impact factor: 3.487

9.  Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.

Authors:  I Shima; Y Sasaguri; J Kusukawa; R Nakano; H Yamana; H Fujita; T Kakegawa; M Morimatsu
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  9 in total
  6 in total

1.  A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer.

Authors:  Xiao-Feng Zeng; Juan Li; Sheng-Bin Li
Journal:  Tumour Biol       Date:  2013-07-31

2.  Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.

Authors:  Yuan-Ping Han; Susan Downey; Warren L Garner
Journal:  Surgery       Date:  2005-11       Impact factor: 3.982

Review 3.  Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

Authors:  Hironori Tsujimoto; Satoshi Ono; Takashi Ichikura; Yusuke Matsumoto; Junji Yamamoto; Kazuo Hase
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

4.  A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.

Authors:  Shunji Matsumura; Naohide Oue; Yasuhiko Kitadai; Kazuaki Chayama; Kazuhiro Yoshida; Yoshiyuki Yamaguchi; Tetsuya Toge; Kazue Imai; Kei Nakachi; Wataru Yasui
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-18       Impact factor: 4.553

Review 5.  Potential mechanisms of tumor progression associated with postoperative infectious complications.

Authors:  Hironori Tsujimoto; Minako Kobayashi; Hidekazu Sugasawa; Satoshi Ono; Yoji Kishi; Hideki Ueno
Journal:  Cancer Metastasis Rev       Date:  2021-01-03       Impact factor: 9.264

6.  Modulation of Cytokines Production by Indomethacin Acute Dose during the Evolution of Ehrlich Ascites Tumor in Mice.

Authors:  Luciana Boffoni Gentile; Nicolle Queiroz-Hazarbassanov; Cristina de Oliveira Massoco; Denise Fecchio
Journal:  Mediators Inflamm       Date:  2015-08-12       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.